8-K/A

FORM 8-K AMENDMENT NO. 1

Company: Skye Bioscience, Inc.
Filed: November 18, 2014
Period of Report: October 31, 2014
Accession Number: 0001557240-14-000713

View Document ↗ View on SEC.gov ↗